We investigated the difference in the biologic nature of typical squamous cell carcinoma (SCC) and basaloid SCC (BSCC) of the larynx by studying proli feration and antiapoptotic markers. We perform ed an immunohistochemical analysis of the expression ojproliferating cell nuclear antigen (PCNA) and bcl-2 protein in 15 patients with laryngealBSCCand 15 stage-and site-matchedcontrols with typical laryngeal SCc. Wefound no significant difference between the twogroups in the PCNA index or thefrequencyofbcl-2 overexpression, nordid wefind any significant differenceinsurvival.Ourfindingsindicatethat the biologicnatureof typicallaryngealSCCand laryngeal BSCC is similar. In addition, ourfollo w-up data suggest that theclinical course oflaryngealBSCCisno worse than that of typical laryngeal SCC.
Introduction
Basaloid squamous cellcarcinoma (BSCC) is an uncommon variant of typical squamous cell carcinoma (SCC) . BSCC has been considered to be a more aggressive neoplasm than typical SCc.'·s The rarity of BSCC in general has heretofore precluded reliable comparisons of the clinical and biologic beh avior oflaryn geal BSCC and SCC; most studies comparin g BSCC and SCC have used samples obt ained from head and neck sites other than th e larynx. As a consequence, the establishment of an appr opriate pro gno stic model for laryngeal BSCC that could be useful for tr eatment planning has been difficult.
Prolifera ting cell nucl ear antigen (PCNA) is a protein th at exists in cell nuclei. It plays a critical role in DNA replic ation and the initiation of cell proliferation. PCNA has been det ected immunohistoch emi cally in par affin sections of normal tissu es and malign ant tissues, such as br east, gastr ic, pan creat ic, renal, and ovarian carcinomas." Th e degree of tumor proliferation is reflected as th e PCNA index,which is expressed as a percentage. A high degree of PCNA expr ession on immunostaining has been reported to indicate an aggressive tumor. '
The bcl-2 protein is a proto-on cogene that promotes oncogenesis by blocking pro grammed cell death (apoptosis ). The overexpression of bcl-2 could provide a potential mechanism for the growth and subsequent overaccumulation of tumor cells in epithelial tissues .
We studied the expression of both PCNA and bcl-2 protein on immunohistochemistry in patients with typical laryngeal sec and laryngeal BSCC, and we correlated our findings with surviv al in the two groups. In this article, we describ e the result s of that study.
Pat ients and methods
With institutional review bo ard approval, we examined patient record sat Erciyes University Hospital forthe years 1997 th rough 2006 and identified 15 cases oflaryngeal BSCC. All cases were reviewed histolo gically by two pathologists (K.D.and T.O.) and analyzed in accorda nce with th e procedures established by Wain et al ( figure) .' In each case, sections were stained with hematoxylin and eosin, periodic acid-Schiff, and Alcian blue. For a control group, we randomly selected 15 patients with stage-and site-match ed typical SCC of the larynx irrespective of tumor grade.All tumor s had been resected without previous radio-or chemotherapy. The staging of the tumors was performed in accordance with th e www.entj ourn al.com • 469 criteria established by the American Joint Committee on Cancer," Formalin-fixed, paraffin-embedded tissue blocks were obtained from Department of Pathology archives. For each carcinoma, we selected one representative block that included both the central and peripheral portions of th e tumor. We mounted 4-flm-thick sections on po ly-L-lysine-coated slides and deparaffin ized and hydrated th em through gra de d alcoho l to wa ter. We removed en dogenous peroxidase by dipping th e sections in 3% hydrogen peroxide for 10 minutes . We then m icrowaved the samples twice for 5 minutes each in 0.1 mollL of a citrate buffer (pH: 6.0). The sections were then incubated with primary antibodies to PCNA (Dako U.S.; Carpinteria, Calif.) and bcl-2 protein (Dako Denmark; Glostrup) for 60 minutes at room temperature and then stained according to the avidine-biotin-peroxidase method. The immunoreaction was visualized with d iam inobenzid ine, and sections were lightly counterstained with Mayer's hematoxylin solution an d th en dehydrat ed and mo unted. Breast carcinoma tissue an d follicular lym phoma tissue were used as the positive controls for PCNA and bcl-2, respectively.
The 2 pathologists acted as independent observers; they scored all the sections while remaining unaware of the clinical outcome in each case. Any cytoplasmic brown staining was accepted as being posi tive for bel-2.Im munoreactivity for bcl-2 was semiquantitatively scored. The extent of immunoreactivity was graded 1+ (+) if less than 25% of tumor cells were positive, 2+ (++) if 25 to 50% of cells were positive, and 3+ (+++) if more than 50% of cells were positive. Tumor cell proliferation was scored by counting PCNA-positive and -negative cells in the maximally im m unostained areas at 400 x magnificatio n. All reactive cells were counted as pos itive regar dless of 470· www.entjournal.com the intensity of staining. In each case, 1,000 cells were counted and the percentage of positive cells was based on that figure .
All statistical analyses were performed with th e SPSS software package (Scientific Package for Social Sciences; to evaluate the hypoth esis th at bcl-2 is expresse d to a significantly greater degree in BSe e th an in typical Sec.
A p value of <0.05 was regard ed as statis tically significant. Th e Kaplan-Meier m eth od was used to calculate the prob abilit y of surv ival. Th e log-rank test was used to compa re Kaplan-Me ier curves.
Results
All patien ts in this study were men. In the cont rol gro up, cytoplasmi c immunoreactivity for bcl-2 was seen in 7 of th e 15 specimens (46.7%) (table 2).A1l7 of these specimens showed focal staining of weak to mod erate int ensity. Th e difference in bcl-2 expressio n between the two groups was no t statistically significant (p = 0.71; chi-squ are test).
Survival. Clinical follow-up was available for all 15 patient swith BSec. Thelength of follow-up ranged from 12 to 108 months (mean: 53.7 ± 31.9). At follow-up, 1 patient had died of disease, 1 was alive with disease, and 13 had no evidence of recur rence or metastasis (table 1) . Follow-up in the cont rol gro up ranged from 16 to 88 mo nt hs (mea n: 48.9 ± 21.3). One of th e 15 patients wit h sec died of disease, 1 died of other causes, and 13 were free of disease (table 2) . Th ere was no statistically significant difference in survival rates between the two gro ups (p = 0.67; log-rank test) .
Discussio n
BSee has a predilection for th e suprag lottic larynx, piriform sinus, and base of th e ton gue."-" Since BSee was first described by Wain et al in 1986,3 no mo re th an www.entjournal.com · 471 50 cases of laryngeal Bsee have been reported in the literature.' :" However, the proportion ofBSees among all cancers of the upper aero digestive tract seems to be increasing. Even though laryngeal Bsee has been considered to be more aggressive than typical see,I-5 Luna et aP2 reported that survival rates associated with the two tumors are similar when stage and site are matched. It has also been suggested that proliferative activity is greater in BSee, resulting in an increase in tumor invasiveness.P:" A high degree of peNA expression in BSee has already been demonstrated." Most comparisons of cell proliferation in Bsee and sec at different anatomic sites, as reflected by a determination of peNA expression, have found that values for Bsee were higher.P'" :"
On the basis of those findings, an apparent correlation between a high degree of cell proliferation and a poor prognosis was established; however, the tumors in these studies were not matched for clinical stage and/or site. A different finding was reported in a small study by Akyol et al, who observed that patients with Bsee had similar proliferation rates and clinical outcomes as did patients with typical sec. I? In other studies, Sampaio-G6es et al recently compared clinical features and peNA expression in 17 patients with primary oral Bsee and 27 patients with poorly differentiated sec matched for stage and site and found no statistically significant differences. IS Moreover, they reported that the degree of peNA expression had no 472· www.entjournal.com prognostic value, as there were no statistically significant differences in 5and lfl-year overall survival, cancer-specificsurvival , and disease-free survival. Sampaio-G6es et al suggested that the clinical and biologic course of oral cavity BSee is similar to that of poorly differentiated oral cavity sec in patients matched for clinical stage.
In the present study, the peNA index was only slightly higher in the laryngeal Bsee group than in the typical laryngeal sec group (58.9vs. 54.1%;p = 0.19) .The lack of statistical significance suggests that the proliferative activity of laryngeal BSee is similar to that of typical sec of the larynx.
Apoptosis as determined by analysis ofbcl-2 protein expression has previously been studied in oral and esophageal Bsee cells, but not in laryngeal Bsee cells. Sarbia et al found a strong expression ofbcl-2 in a series of23 BSees of the esophagus.I'Theyreported that bcl-2 expression is increased as the epithelial differentiation decreases. They also reported that the strong expression of bcl-2 was probably associated with the aggressive progression of BSec. Koide et al suggested that overexpression ofbcl-2 protein in esophageal Bsee might be associated with the aggressiveness of this tumor." Sampaio-G6es et al, in their study of 17 patients with primary oral Bsee and 27 patients with poorly differentiated oral sec matched for tumor stage, found that the expression ofBcl-X protein was remarkable in both groups and that there was no statistically significant difference between the two groups.IS However, they did ENT-Ear, Nose & Throat Journal-August 2008 find that the difference in immunoexpression of the proapoptotic protein Bax was statistically significant, although this difference did not affect the clinical course in terms of overall survival.
In our study, the immunohistochemical expression of bcl-2 was stronger and more common in the BSee specimens than in the sec specimens. But again, the difference in frequency-53.3 vs. 46.7%-was not statistically significant (p = 0.71). We also found that proliferative activity in laryngeal BSee is similar to that of typical sec and that the rate of spontaneous apoptosis as determined by the expression ofbcl-2 was similar in the two groups, even though almost all of the tumors in the control group were either well differentiated or moderately differentiated. Finally,overall sur vival in the two groups of patients was statist ically equivalent.
Weare aware that our BSee study group included only 15 patients, but pr evious reports that have implied the aggressive behavior of laryngeal Bsee have primarily been based on reports of single cases.":" To our knowledge, ours is the only relatively large study to compare laryngeal Bsee with stage-and site-matched typical sec that has been reported to date.
In conclusion, the premise that BSee is clinically or biologically more aggressivethan typical sec cannot be supported with respect to tumors of the laryn x. When matched for stage and site, th ese tumors carry a similar prognosis. Therefore, institution of similar treatment protocols appears to be reasonable. 
